Free Trial

Marker Therapeutics (MRKR) SEC Filings & 10K Form

Marker Therapeutics logo
$3.00 -0.18 (-5.66%)
(As of 12:05 PM ET)

Recent Marker Therapeutics SEC Filings

DateFilerForm TypeView
08/14/2024
3:47 PM
Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
3:39 PM
Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2024
6:12 AM
Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/17/2024
5:25 PM
Marker Therapeutics, Inc. (Subject)
Marker Therapeutics (Subject)
New Enterprise Associates 16, L.P. (Filed by)
Form SC 13D/A
05/15/2024
3:40 PM
Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2024
6:09 AM
Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2024
7:02 AM
Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2024
6:58 AM
Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
7:30 AM
Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2023
6:35 AM
Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2023
3:37 PM
Marker Therapeutics, Inc. (Filer)
Marker Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MRKR) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners